Brian Fahie, Ph.D.Global Head, Vice President at BiogenSpeaker
Profile
Brian Fahie, Ph.D. currently is the Global Head of the Quality Control team at Biogen supporting the testing, characterization, and release of the Biogen commercial and late phase clinical portfolio (Proteins, Small Molecules, Antisense Oligonucleotides, and Devices). Prior to this role, Brian was responsible for the Analytical Development team at Biogen supporting the Product Development portfolio where he was responsible for the development of innovative testing strategies optimized around decision making, the strategic use of automated solutions, and external partner capabilities and capacities.
Agenda Sessions
Automation along the Analytical Development Quality Control Continuum: Why, When, and How to Automate in the Everchanging World of Development and When Should Automation Solutions be Transferred to the QC Laboratories?
, 2:30pmView Session